UNLIMITED TURBO SHORT - AMGEN | Market Closed - Deutsche Boerse AG 20:50:25 17/05/2024 BST | ||
| 9.77 EUR | +3.06% |
|
| Current month | -28.00% | ||
| 1 month | -32.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 9.77 | +3.06% |
| 16/05/24 | 9.48 | +2.27% |
| 15/05/24 | 9.27 | -7.76% |
| 14/05/24 | 10.05 | -3.55% |
| 13/05/24 | 10.42 | +2.26% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN9XLL |
| ISIN | DE000PN9XLL2 |
| Date issued | 18/10/2023 |
| Strike | 416.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 12.87 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.19 € |
|---|---|
| Lowest since issue | 8.79 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
